Peptide Therapy · Learning Library
An educational look at AOD-9604, a modified fragment of growth hormone studied for fat metabolism, and what clinical trials found.
AOD-9604 is a lab-made peptide based on the tail end of human growth hormone, the part that's thought to be involved in breaking down fat.
AOD-9604 has mostly been talked about for fat loss, and more recently for joint and cartilage support.
It went through human trials for obesity, and those trials did not show enough weight loss compared with placebo, so development for weight loss was stopped. It is not FDA-approved as a drug.
In the trials it was generally well tolerated. Long-term safety data is limited.
If you're curious whether peptides fit into your health goals, a licensed provider can look at your history and labs and talk through the evidence, the risks and your options.
AOD-9604 is a lab-made peptide based on the tail end of human growth hormone, the part that's thought to be involved in breaking down fat.
It was designed to keep growth hormone's fat-burning signal without raising IGF-1 or affecting blood sugar the way full growth hormone can. In lab and animal studies, it appeared to increase lipolysis, which is the breakdown of stored fat, and reduce fat building.
AOD-9604 has mostly been talked about for fat loss, and more recently for joint and cartilage support.
It is not FDA-approved as a drug. Rules around peptides have been changing, so talk with a licensed provider before starting any treatment.
In the trials it was generally well tolerated. Long-term safety data is limited.
This article is general education and isn't medical advice, and it isn't a recommendation to use any substance. Information about research and regulations can change. Talk with a licensed healthcare provider before starting any treatment.